The term idiopathic short stature (ISS) refers to short children with no identifiable disorder of the growth hormone (GH)/insulin like growth factor (IGF) axis and no other endocrine, genetic or organ system disorder. This heterogeneous group of short children without GH deficiency (GHD) includes children with constitutional delay of growth and puberty, familial short stature, or both, as well as those with subtle cartilage and bone dysplasias. In rare cases, ISS is due to IGF molecular abnormalities. In this review we tackle the major challenges in the definition and treatment of ISS.
Pedicelli, S., Peschiaroli, E., Violi, E., Cianfarani, S. (2009). Controversies in the definition and treatment of idiopathic short stature ISS. JOURNAL OF CLINICAL RESEARCH IN PEDIATRIC ENDOCRINOLOGY, 1(3), 105-115.
Controversies in the definition and treatment of idiopathic short stature ISS.
CIANFARANI, STEFANO
2009-01-01
Abstract
The term idiopathic short stature (ISS) refers to short children with no identifiable disorder of the growth hormone (GH)/insulin like growth factor (IGF) axis and no other endocrine, genetic or organ system disorder. This heterogeneous group of short children without GH deficiency (GHD) includes children with constitutional delay of growth and puberty, familial short stature, or both, as well as those with subtle cartilage and bone dysplasias. In rare cases, ISS is due to IGF molecular abnormalities. In this review we tackle the major challenges in the definition and treatment of ISS.| File | Dimensione | Formato | |
|---|---|---|---|
|
JCRPE 2009.pdf
solo utenti autorizzati
Licenza:
Creative commons
Dimensione
428.22 kB
Formato
Adobe PDF
|
428.22 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Questo articolo è pubblicato sotto una Licenza Licenza Creative Commons
